assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001746615.1_ASM174661v1	NZ_CP013961	Xanthomonas oryzae pv. oryzae strain PXO145, complete genome	1	4252886-4258482	1,1,1	PILER-CR,CRISPRCasFinder,CRT	no	cas3,cas5,cas8c,cas7,cas4,cas1,cas2	cas3,DinG,csa3,DEDDh,WYL,cas5,cas8c,cas7,cas4,cas1,cas2	 Type I-U?,Type I-C,Type I-U	GTCGCGTCCTCACGGGCGCGTGGATTGAAAC,GTCGCGTCCTCACGGGCGCGTGGATTGAAAC,GTCGCGTCCTCACGGGCGCGTGGATTGAAAC	31,31,31	1	1	4256059-4256092	NZ_CP013961.1_2118398-2118431	I-C:I-C:I-C	85,85,85	85	TypeI-U?,TypeI-C,TypeI-U	cas3,DinG,csa3,DEDDh,WYL,cas5,cas8c,cas7,cas4,cas1,cas2	NA,NA	NA|170aa|up_9|NZ_CP013961.1_4242241_4242751_-	COG1399, COG1399, Predicted metal-binding, possibly nucleic acid-binding protein [General function prediction only]	NA|192aa|up_8|NZ_CP013961.1_4242863_4243439_+	PRK00884, PRK00884, Maf-like protein; Reviewed	NA|322aa|up_7|NZ_CP013961.1_4243829_4244795_-	pfam12762, DDE_Tnp_IS1595, ISXO2-like transposase domain	cas3|764aa|up_6|NZ_CP013961.1_4244906_4247198_+	cd17930, DEXHc_cas3, DEXH/Q-box helicase domain of Cas3	cas5|225aa|up_5|NZ_CP013961.1_4247325_4248000_+	cd09752, Cas5_I-C, CRISPR/Cas system-associated RAMP superfamily protein Cas5	cas8c|615aa|up_4|NZ_CP013961.1_4247996_4249841_+	cd09757, Cas8c_I-C, CRISPR/Cas system-associated protein Cas8c	cas7|289aa|up_3|NZ_CP013961.1_4249837_4250704_+	pfam05107, Cas_Cas7, CRISPR-associated protein Cas7	cas4|211aa|up_2|NZ_CP013961.1_4250723_4251356_+	TIGR00372, conserved_hypothetical_protein, CRISPR-associated protein Cas4	cas1|345aa|up_1|NZ_CP013961.1_4251358_4252393_+	TIGR03640, cas1_DVULG, CRISPR-associated endonuclease Cas1, subtype I-C/DVULG	cas2|97aa|up_0|NZ_CP013961.1_4252407_4252698_+	cd09725, Cas2_I_II_III, CRISPR/Cas system-associated protein Cas2	NA|280aa|down_0|NZ_CP013961.1_4259856_4260696_-	COG1216, COG1216, Predicted glycosyltransferases [General function prediction only]	NA|386aa|down_1|NZ_CP013961.1_4261306_4262464_+	cd05153, HomoserineK_II, Type II Homoserine Kinase	NA|721aa|down_2|NZ_CP013961.1_4262499_4264662_+	TIGR01783, Ferrienterobactin_receptor, TonB-dependent siderophore receptor	NA|192aa|down_3|NZ_CP013961.1_4265037_4265613_+	pfam04973, NMN_transporter, Nicotinamide mononucleotide transporter	NA|243aa|down_4|NZ_CP013961.1_4265718_4266447_+	TIGR03337, phnR, phosphonate utilization transcriptional regulator PhnR	NA|280aa|down_5|NZ_CP013961.1_4266884_4267724_-	COG1216, COG1216, Predicted glycosyltransferases [General function prediction only]	NA|771aa|down_6|NZ_CP013961.1_4267720_4270033_-	TIGR02517, Putative_type_II_secretion_system_protein_D, type II secretion system protein D	NA|270aa|down_7|NZ_CP013961.1_4270029_4270839_-	PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated	NA|218aa|down_8|NZ_CP013961.1_4270828_4271482_-	pfam10741, T2SSM_b, Type II secretion system (T2SS), protein M subtype b	NA|374aa|down_9|NZ_CP013961.1_4271465_4272587_-	pfam05137, PilN, Fimbrial assembly protein (PilN)
